Page 60 | Certara

On-Demand Webinar

Using Quantitative Systems Pharmacology (QSP) Modeling for Oncology Dose Optimization

The FDA’s Project Optimus initiative aims to reform dose optimization and selection for oncology therapies…

CertaraAugust 19, 2024

Blog

Automation in clinical trials: Why it’s essential for success

Many companies in the life sciences industry are slow to adopt new technologies. This is…

CertaraAugust 19, 2024

Blog

Subject Exposure in Aggregate Safety Reports & Common Issues

All new and existing drugs should be safe, effective, and efficacious for the treated populations.…

CertaraAugust 16, 2024

Case Study

Optimizing Clinical Development: Saving Time and Costs

Strategic mechanistic modeling solutions help an immunoncology biotech accelerate their clinical development of novel therapeutics.

CertaraAugust 16, 2024

Press Release

Certara Launches Phoenix™ Version 8.5 Drug Development Software

RADNOR, PA – August 15, 2024 - Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraAugust 15, 2024

Announcement

Certara Research Reveals IRA’s Impact on Biosimilar Uptake

RADNOR, PA - August 15, 2024 -- Certara, Inc., a global leader in model-informed drug…

CertaraAugust 15, 2024

Case Study

Medicines that matter: Biohaven’s Nurtec™ drug development journey

In February 2020, Biohaven Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) approved…

CertaraAugust 15, 2024

On-Demand Webinar

Mastering Value Storytelling in Healthcare: Leveraging Digital Tools to Meet Stakeholders’ Expectations

Everyone loves a good story. Stories are more likely to move and engage people than…

CertaraAugust 14, 2024

White Paper

Evaluating the IRA’s Impact on Medicare Part B Biosimilar Reimbursement

White paper exploring the IRA’s small but measurable impact in several key areas

CertaraAugust 13, 2024

SDTM controlled terminology - All You Need to Know

Blog

All you need to know about NCI, CDISC and SDTM controlled terminology

The use of controlled terminology (CT) is vital to successful clinical study build. In clinical…

CertaraAugust 13, 2024

Using Quantitative Systems Pharmacology (QSP) Modeling for Oncology Dose Optimization

Automation in clinical trials: Why it’s essential for success

Subject Exposure in Aggregate Safety Reports & Common Issues

Optimizing Clinical Development: Saving Time and Costs

Certara Launches Phoenix™ Version 8.5 Drug Development Software

Certara Research Reveals IRA’s Impact on Biosimilar Uptake

Medicines that matter: Biohaven’s Nurtec™ drug development journey

Mastering Value Storytelling in Healthcare: Leveraging Digital Tools to Meet Stakeholders’ Expectations

Evaluating the IRA’s Impact on Medicare Part B Biosimilar Reimbursement

All you need to know about NCI, CDISC and SDTM controlled terminology

Newsletter sign up

Quick links

Solutions

Contact